Cardiff Oncology, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cardiff Oncology, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2011 to Q3 2024.
  • Cardiff Oncology, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 48.7M shares, a 9.07% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 48.7M +4.05M +9.07% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 45.6M +925K +2.07% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 44.7M +33K +0.07% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 44.7M 0 0% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 44.7M +1.34M +3.1% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 44.7M +1.37M +3.17% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 44.7M +1.37M +3.17% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 44.7M +2.71M +6.47% Dec 31, 2022 10-K 2024-02-29
Q3 2022 43.3M +3.78M +9.57% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 43.3M +3.75M +9.49% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 43.3M +5.75M +15.3% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 42M +5.18M +14.1% Dec 31, 2021 10-K 2023-03-02
Q3 2021 39.6M +13.3M +50.5% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 39.6M +18.2M +85.5% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 37.6M +31.1M +483% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 36.8M +28.2M +328% Dec 31, 2020 10-K 2022-02-24
Q3 2020 26.3M +19.8M +308% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 21.3M +15.9M +292% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 6.44M +1.91M +42.2% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 8.59M +4.76M +124% Dec 31, 2019 10-K 2021-02-25
Q3 2019 6.44M -16.5M -72% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 5.44M -11.9M -68.6% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 4.53M -54.3M -92.3% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 3.83M +3.1M +423% Dec 31, 2018 10-K 2020-02-27
Q3 2018 23M -15.1M -39.8% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 17.3M -13.8M -44.3% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 58.8M +27.9M +90% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 733K -30M -97.6% Dec 31, 2017 10-K 2019-03-06
Q3 2017 38.1M +7.51M +24.5% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 31.1M +660K +2.17% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 31M +1.19M +3.98% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 30.7M +959K +3.23% Dec 31, 2016 10-K 2018-02-26
Q3 2016 30.6M +877K +2.95% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 30.4M +5.54M +22.3% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 29.8M +5.48M +22.5% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 29.7M +10.8M +57.2% Dec 31, 2015 10-K 2017-03-15
Q3 2015 29.7M +10.8M +57.2% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 24.9M +5.97M +31.6% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 24.3M +5.4M +28.6% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 18.9M +13K +0.07% Dec 31, 2014 10-K 2016-03-10
Q3 2014 18.9M +10.8K +0.06% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 18.9M +3.17M +20.2% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 18.9M +3.39M +21.8% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 18.9M +3.42M +22.1% Dec 31, 2013 10-K 2015-03-12
Q3 2013 18.9M +4.71M +33.2% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 15.7M +1.55M +11% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 15.5M -51.6M -76.9% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 15.5M +4.74M +44.2% Dec 31, 2012 10-K 2014-03-17
Q3 2012 14.2M Sep 30, 2012 10-Q 2012-11-14
Q2 2012 14.2M Jun 30, 2012 10-Q 2012-08-14
Q1 2012 67.1M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 10.7M Dec 31, 2011 10-K 2013-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.